Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesChange in TaxesDepreciation & Amortization (CF)Depreciation and DepletionDivestmentsDividends Paid - CommonFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesSales of Property, Plant and EquipmentShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Fortress Biotech (FBIO) Gains from Investment Securities (2016 - 2025)

Historic Gains from Investment Securities for Fortress Biotech (FBIO) over the last 13 years, with Q3 2025 value amounting to $540000.0.

  • Fortress Biotech's Gains from Investment Securities changed 0.0% to $540000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $540000.0, marking a year-over-year change of 0.0%. This contributed to the annual value of $9.0 million for FY2024, which is 664142.15% up from last year.
  • Fortress Biotech's Gains from Investment Securities amounted to $540000.0 in Q3 2025, which was down 0.0% from $540000.0 recorded in Q2 2025.
  • Fortress Biotech's 5-year Gains from Investment Securities high stood at $1.5 million for Q4 2022, and its period low was -$104000.0 during Q1 2023.
  • Its 5-year average for Gains from Investment Securities is $289842.6, with a median of $94000.0 in 2023.
  • Its Gains from Investment Securities has fluctuated over the past 5 years, first tumbled by 426000.0% in 2023, then surged by 32520120.48% in 2024.
  • Quarter analysis of 5 years shows Fortress Biotech's Gains from Investment Securities stood at $332000.0 in 2021, then surged by 349.1% to $1.5 million in 2022, then plummeted by 92.29% to $115000.0 in 2023, then plummeted by 36.52% to $73000.0 in 2024, then skyrocketed by 639.73% to $540000.0 in 2025.
  • Its last three reported values are $540000.0 in Q3 2025, $540000.0 for Q2 2025, and $540000.0 during Q1 2025.